The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Mechanisms of Antibiotic Resistance in Burkholderia Pseudomallei : Implications for Treatment of Melioidosis
Open accessAbstract
Burkholderia pseudomallei is the etiologic agent of melioidosis. This multifaceted disease is difficult to treat, resulting in high morbidity and mortality. Treatment of B. pseudomallei infections is lengthy and necessitates an intensive phase (parenteral ceftazidime, amoxicillin-clavulanic acid or meropenem) and an eradication phase (oral trimethoprim-sulfamethoxazole). The main resistance mechanisms affecting these antibiotics include enzymatic inactivation, target deletion and efflux from the cell, and are mediated by chromosomally encoded genes. Overproduction and mutations in the class A PenA β-lactamase cause ceftazidime and amoxicillin-clavulanic acid resistance. Deletion of the penicillin binding protein 3 results in ceftazidime resistance. BpeEF-OprC efflux pump expression causes trimethoprim and trimethoprim-sulfamethoxazole resistance. Although resistance is still relatively rare, therapeutic efficacies may be compromised by resistance emergence due to increased use of antibiotics in endemic regions. Novel agents and therapeutic strategies are being tested and, in some instances, show promise as anti-B. pseudomallei infectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Melioidosis: Epidemiology, Pathophysiology, and Management
Cheng, A. C., & Currie, B. J. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.383-416.2005 · Cited by 1,464
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Currie, B. J., Ward, L., & Cheng, A. C. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000900 · Cited by 771
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
White, N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13374-0 · Cited by 760
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei
Holden, M. T. G., Titball, R. W., Peacock, S. J., Cerdeño-Tárraga, A. M., Atkins, T., Crossman, L. C., Pitt, T., Churcher, C., Mungall, K., Bentley, S. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403302101 · Cited by 758
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei
Wiersinga, W. J., van der Poll, T., White, N. J., Day, N. P., & Peacock, S. J. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1385 · Cited by 585
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram‐Negative Bacteria
Hancock, R. E. W. (1998) · Clinical Infectious Diseases · doi:10.1086/514909 · Cited by 583
Bacterial resistance to antibiotics: Active efflux and reduced uptake
KUMAR, A., & SCHWEIZER, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 529
Self-citationEfflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei
Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A., & Woods, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.465 · Cited by 305
Tal, N., & Schuldiner, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902400106 · Cited by 195
Management of Accidental Laboratory Exposure to Burkholderia pseudomallei and B. mallei
Peacock, S. J., Schweizer, H. P., Dance, D. A. B., Smith, T. L., Gee, J. E., Wuthiekanun, V., DeShazer, D., Steinmetz, I., Tan, P., & Currie, B. J. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1407.071501 · Cited by 174
Self-citationThree's company: component structures bring a closer view of tripartite drug efflux pumps
Eswaran, J., Koronakis, E., Higgins, M. K., Hughes, C., & Koronakis, V. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.10.003 · Cited by 162
Dance, D. A. B., Wuthiekanun, V., Chaowagul, W., & White, N. J. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.3.295 · Cited by 152
Adler, N. R. L., Govan, B., Cullinane, M., Harper, M., Adler, B., & Boyce, J. D. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00189.x · Cited by 147
Evolution of Burkholderia pseudomallei in Recurrent Melioidosis
Hayden, H. S., Lim, R., Brittnacher, M., Sims, E. H., Ramage, E. R., Fong, C. T., Wu, Z., Crist, E. M., Chang, J., Zhou, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036507 · Cited by 128
Wuthiekanun, V., & Peacock, S. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.3.445 · Cited by 122
Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis
Koh, G. C. K. W., Maude, R. R., Schreiber, M. F., Limmathurotsakul, D., Wiersinga, W. J., Wuthiekanun, V., Lee, S. J., Mahavanakul, W., Chaowagul, W., Chierakul, W., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq192 · Cited by 118
Chantratita, N., Rholl, D. A., Sim, B., Wuthiekanun, V., Limmathurotsakul, D., Amornchai, P., Thanwisai, A., Chua, H. H., Ooi, W. F., Holden, M. T. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111020108 · Cited by 117
Self-citationBpeAB-OprB, a Multidrug Efflux Pump in Burkholderia pseudomallei
Chan, Y. Y., Tan, T. M. C., Ong, Y. M., & Chua, K.-L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1128-1135.2004 · Cited by 116
Mima, T., & Schweizer, H. P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01803-09 · Cited by 109
Self-citationTribuddharat, C., Moore, R. A., Baker, P. L., & Woods, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2082-2087.2003 · Cited by 105
Sarovich, D. S., Price, E. P., Schulze, A. T. V., Cook, J. M., Mayo, M. J., Watson, L. M., Richardson, L. J., Seymour, M. L., Tuanyok, A., Engelthaler, D. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030789 · Cited by 103
Sawasdidoln, C., Taweechaisupapong, S., Sermswan, R. W., Tattawasart, U., Tungpradabkul, S., & Wongratanacheewin, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009196 · Cited by 101
Peacock, S. J., Limmathurotsakul, D., Lubell, Y., Koh, G. C. K. W., White, L. J., Day, N., & Titball, R. W. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001488 · Cited by 97
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei
Wuthiekanun, V., Cheng, A. C., Chierakul, W., Amornchai, P., Limmathurotsakul, D., Chaowagul, W., Simpson, A. J. H., Short, J. M., Wongsuvan, G., Maharjan, B., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki151 · Cited by 95
Kumar, A., Chua, K.-L., & Schweizer, H. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00440-06 · Cited by 90
Self-citationMolecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei
Rholl, D. A., Papp‐Wallace, K. M., Tomaras, A. P., Vasil, M. L., Bonomo, R. A., & Schweizer, H. P. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00139 · Cited by 84
Self-citationAdaptation and Antibiotic Tolerance of Anaerobic Burkholderia pseudomallei
Hamad, M. A., Austin, C., Stewart, A. L., Higgins, M., Vázquez‐Torres, A., & Voskuil, M. I. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00953-10 · Cited by 82
Novem, V., Shui, G., Wang, D., Bendt, A. K., Sim, S. H., Liu, Y., Thong, T. W., Sivalingam, S. P., Ooi, E. E., Wenk, M. R., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00472-08 · Cited by 81
Burtnick, M. N., & Woods, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2648 · Cited by 78
Wiersinga, W. J., Veer, C. V. ′., van den Pangaart, P. S., Dondorp, A. M., Day, N., Peacock, S. J., & van der Poll, T. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e318194b1bf · Cited by 74
Vorachit, M., Lam, K., Jayanetra, P., & Costerton, J. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.2000 · Cited by 73
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
Sarovich, D. S., Price, E. P., Peacock, S. J., Cook, Vonschulze, Wolken, Keim, Pearson, T., & Limmathurotsakul, D. (2012) · Infection and Drug Resistance · doi:10.2147/idr.s35529 · Cited by 73
Melioidosis: advances in diagnosis and treatment
Cheng, A. C. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833fb88c · Cited by 62
Häußler, S., Rohde, M., & Steinmetz, I. (1999) · Medical Microbiology and Immunology · doi:10.1007/s004300050110 · Cited by 55
Progress toward development of vaccines against melioidosis: A review
Sarkar‐Tyson, M., & Titball, R. W. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.020 · Cited by 51
Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms
Pibalpakdee, P., Wongratanacheewin, S., Taweechaisupapong, S., & Niumsup, P. R. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.010 · Cited by 50
Niumsup, P. R. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf165 · Cited by 48
Propst, K. L., Troyer, R. M., Kellihan, L. M., Schweizer, H. P., & DOW, S. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01513-09 · Cited by 48
Self-citationBiot, F., Valade, E., Garnotel, É., Chevalier, J., Villard, C., Thibault, F., Vidal, D. R., & Pagès, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016892 · Cited by 46
Antibiotic resistance: multidrug efflux proteins, a common transport mechanism?
Langton, K. P., Henderson, P. J. F., & Herbert, R. B. (2005) · Natural Product Reports · doi:10.1039/b413734p · Cited by 46
Cloning and Expression of Class A β-Lactamase Gene blaA BPS in Burkholderia pseudomallei
Cheung, T. K. M., Ho, P., Woo, P. C. Y., Yuen, K., & Chau, P. Y. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1132-1135.2002 · Cited by 37
Ho, P., Cheung, T. K. M., Yam, W. C., & Yuen, K. Y. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf208 · Cited by 31
Molecular Characterization of Clinical Burkholderia pseudomallei Isolates from India
Mukhopadhyay, C., Kaestli, M., Vandana, K. E., Sushma, K., Mayo, M. J., Richardson, L. J., Tuanyok, A., Keim, P., Godoy, D., Spratt, B. G., et al. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.11-0166 · Cited by 27
Schweizer, H. P. (2012) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2012.00334.x · Cited by 18
Self-citationBioterrorism and Infectious Agents
Somberg, J. C. (2006) · American Journal of Therapeutics · doi:10.1097/00045391-200603000-00021 · Cited by 17
Cited by
Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
Blair, J. M., Richmond, G. E., & Piddock, L. J. (2014) · Future Microbiology · doi:10.2217/fmb.14.66 · Cited by 481
Antibiotic resistance in Burkholderia species
Rhodes, K. A., & Schweizer, H. P. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.07.003 · Cited by 405
Self-citation
Metadata
- Authors
- Schweizer, H. P.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2012-12
- Volume
- 7
- Issue
- 12
- Pages
- 1389-1399
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2095871644
- Cited by
- 259
- References
- 52
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.